“Apremilast in Pediatric Patients With Moderate to Severe Plaque Psoriasis: 16-Week Efficacy and Safety Results From the Phase 3, Randomized, Double-Blind, Placebo-Controlled SPROUT Study”. SKIN The Journal of Cutaneous Medicine 7, no. 6 (November 13, 2023): s254. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/2441.